Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro

Journal of Cellular Physiology

Volumn 156, Issue 2, 1993, Pages 235-246

  Schnaper, H William ^a,b   Grant, Derrick S ^a   Stetler‐Stevenson, William G ^c   Fridman, Rafael ^d   D'Orazi, Gabriella ^c   Murphy, Anne N ^c   Bird, Robert E ^d   Hoythya, Matti ^d   Fuerst, Thomas R ^d   French, Deborah L ^e   Quigley, James P ^e   Kleinman, Hynda K ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Molecular Oncology Inc ^*  (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CELL DIFFERENTIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MORPHOGENESIS; PRIORITY JOURNAL; UMBILICAL VEIN;

AMINO ACID SEQUENCE; ANTIBODIES; BASEMENT MEMBRANE; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; COLLAGENASES; DRUG COMBINATIONS; DRUG INTERACTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; GELATINASE B; GLYCOPROTEINS; HUMAN; LAMININ; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MORPHOGENESIS; NEOPLASM PROTEINS; PROTEOGLYCANS; RECOMBINANT PROTEINS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; TISSUE INHIBITOR-OF METALLOPROTEINASE-2; UMBILICAL VEINS;

EID: 0027178718     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041560204     Document Type: Article

References (53)

1. Migration and proliferation of endothelial cells in preformed and newly formed vessels during tumor angiogenesis
2. Proteolytic enzymes as mediators of glomerular injury
3. In vitro model of angiogenesis using a human endothelium‐derived permanent cell line: Contributions of induced gene expression, G‐proteins, and integrins
4. Detergent‐activation of latent collagenase and resolution of its component molecules
5. Genes for extracellular matrix‐degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development
6. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines
7. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor
8. H‐ras oncogene‐transformed human bronchial epithelial cells (TBE‐1) secrete a single metalloprotease capable of degrading basement membrane collagen
9. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells
10. Toward an understanding of angiogenesis: Search and discovery
11. What is the evidence that tumors are angiogenesis dependent?
12. Angiogenesis in vitro
13. Domain structure of human 72‐kDa gelatinase/type IV collagenase: Characterization of proteolytic activity and identification of TIMP‐2 binding sites
14. Establishment of human mucosal microvascular endothelial cells from inferior turbinate in culture
15. Tumor growth and neovascularization: An experimental model using the rabbit cornea
16. Ribonucleic acid isolated by cesium chloride centrifugation
17. Human 72‐kilodalton type IV collagenase forms a complex with tissue inhibitor of metalloproteinases designated TIMP‐2
18. Interaction of 92‐kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin
19. Two different domains of laminin mediate the differentiation of human endothelial cells into capillary‐like structures in vitro
20. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro
21. Plasminogen activator and collagenase production by cultured capillary endothelial cells
22. Isolation and culture of microvascular endothelium from human adipose tissue
23. Tumor angiogenesis activity in cells grown in tissue culture
24. Basement membrane complexes with biological activity
25. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary‐like structures
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
27. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
28. Organizational behavior of human umbilical vein endothelial cells
29. Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of deendothelialization and repair
30. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor‐induced proteinases
31. Tumor promoter‐stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells
32. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene
33. Identification of an inhibitor of neovascularization from cartilage
34. Developmental expression of tissue inhibitor of metallo‐proteinase (TIMP) mRNA
35. The role of endothelial cells in inflammation
36. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis
37. Hyperlipidemia and atherosclerosis
38. Proteoglycans as modulators of growth factor activities
39. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells—role in metastasis
40. Transforming growth factor‐β1 up‐regulates type IV collagenase expression in cultured human keratinocytes
41. Tissue inhibitor of metalloproteinase (TIMP‐2)
42. Tissue inhibitor of metalloproteinases‐2 (TIMP‐2) mRNA expression in tumor cell lines and human tumor tissues
43. Reorganization of basement membrane matrices by cellular traction promotes the formation of cellular networks in vitro
44. Identification of multiple growth factors in basement membrane matrigel suggest caution in interpretation of cellular activity related to extracellular matrix components
45. Development of a novel substrate capture immunoassay for the detection of a neutral metalloproteinase capable of degrading basement membrane (type IV) collagen
46. Function follows form: Generation of intracellular signals by cell deformation
47. Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma
48. Human skin fibroblast inhibitor. Comparative studies in human connective tissue, serum, and amniotic fluid
49. SV40‐transformed human lung fibroblasts secrete a 92‐kDa type IV collagenase which is identical to that secreted by normal human macrophages
50. Matrix metalloproteinases and their inhibitors in connective tissue remodelling
51. Endothelial turnover
52. Molecular architecture of basement membranes